1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Vietnam Pharmaceuticals and Healthcare Report Q1 2016

Vietnam Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 107 pages

Includes 3 FREE quarterly updates

BMI View: Vietnam will be a highly attractive market for private healthcare providers in the regionBeyond the expected strong increases in healthcare spending, there are also significant service gaps in themarket that will provide revenue earning opportunities to companies looking to invest in the sector Thesestem from the underdeveloped state of the public health sector characterised by overcrowded hospitals andpatients with limited access to advanced medical treatments This will in turn affect the strategies employedby pharmaceutical firms, as private hospitals will present an alternative sales channel for high valuemedicines

Headline Expenditure Projections

- Pharmaceuticals: VND8073trn (USD381bn) in 2014 to VND9247trn (USD417bn) in 2015; +145%in local currency terms and +94% in US dollar terms Forecast unchanged from last quarter

- Healthcare: VND23491trn (USD1108bn) in 2014 to VND25867bn (USD1166bn) in 2015; +101% inlocal currency terms and +52% in US dollar terms Forecast unchanged from last quarter

Table Of Contents

Vietnam Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Vietnam 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Vietnam 2011-2019) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2011-2019) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2011-2019) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2011-2019) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Vietnam 2011-2019) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Vietnam 2011-2019) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Vietnam 2011-2019) 26
OTC Medicine Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Vietnam 2011-2019) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Vietnam 2013-2019) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Vietnam 2013-2019) 32
Pharmaceuticals and Healthcare Risk/Reward Index 33
Asia Pacific Risk/Reward Index 33
Vietnam Risk/Reward Index 40
Rewards 40
Risks 40
Regulatory Review 42
Pharmaceutical Advertising 43
Intellectual Property Issues 44
Corruption 47
Pricing Regime 48
Reimbursement Regime 53
Pricing And Reimbursement Developments 54
Market Overview 56
Healthcare Sector 57
Hospital Sector 60
Table: Healthcare Resources (Vietnam 2009-2014) 60
Table: Healthcare Personnel (Vietnam 2009-2014) 60
Table: Healthcare Activity (Vietnam 2009-2014) 61
Private Healthcare Sector 63
Healthcare Insurance 64
Healthcare And Pharmaceutical Reform 65
Research And Development 66
Biotechnology Sector 67
Clinical Trials 70
Competitive Landscape 75
Research-Based Industry 75
Domestic Industry 76
Foreign Industry 77
Traditional Medicines 78
Table: Multinational Market Activity 79
Pharmaceutical Distribution 80
Pharmaceutical Retail Sector 81
Table: Key Aspects Of Good Pharmacy Practice In Developing Countries 82
Company Profile 83
DHG Pharmaceutical 83
GlaxoSmithKline 86
Sanofi 88
Traphaco Pharmaceutical 91
Vietnam Pharmaceutical Corporation (Vinapharm) 93
Demographic Forecast 96
Table: Population Headline Indicators (Vietnam 1990-2025) 97
Table: Key Population Ratios (Vietnam 1990-2025) 97
Table: Urban/Rural Population and Life Expectancy (Vietnam 1990-2025) 98
Table: Population By Age Group (Vietnam 1990-2025) 98
Table: Population By Age Group % (Vietnam 1990-2025) 99
Glossary 101
Methodology 103
Pharmaceutical Expenditure Forecast Model 103
Healthcare Expenditure Forecast Model 103
Notes On Methodology 104
Risk/Reward Index Methodology 105
Index Overview 106
Table: Pharmaceutical Risk/Reward Index Indicators 106
Indicator Weightings 107

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.